Mephaquin Lactab

Mefloquine, the active ingredient in Mephaquin Lactab, is a quinoline antimalarial presented as an oral tablet for oral use. It is employed for the prevention of malaria and for the treatment of malaria caused by Plasmodium falciparum in adults and children as directed by a healthcare professional.

GNH USA supplies Mephaquin Lactab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global health programs.

Mefloquine is a quinoline antimalarial used in both prophylaxis and treatment of malaria infections.

- Malaria prophylaxis: prevents infection in travelers and residents exposed to malaria‑endemic regions. - Uncomplicated Plasmodium falciparum malaria: treats acute infection, including chloroquine‑resistant strains. - Multidrug‑resistant malaria: used as part of combination therapy when other agents are ineffective.

Mefloquine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dizziness: sensation of light‑headedness or vertigo. - Insomnia: difficulty falling or staying asleep. - Headache: persistent or throbbing pain. - Visual disturbances: blurred vision or altered color perception. - Gastrointestinal upset: abdominal pain or diarrhea.

Serious or Rare Side Effects: - Neuropsychiatric reactions: depression, anxiety, psychosis, or suicidal thoughts. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Cardiac arrhythmias: QT interval prolongation leading to irregular heartbeat. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Seizures: convulsive episodes in susceptible individuals.

Before prescribing Mephaquin Lactab, clinicians should evaluate patient history and monitor for specific risks.

- Assess medical history: review prior psychiatric or cardiac conditions. - Evaluate contraindications: avoid in patients with known hypersensitivity to mefloquine. - Monitor neuropsychiatric symptoms: watch for mood changes, anxiety, or hallucinations. - Use caution in hepatic impairment: adjust therapy if liver function is compromised. - Avoid in patients with a history of seizures: consider alternative agents. - Store below 25°C: keep in the original pack, protect from moisture.

Mefloquine can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid):\n- Quinidine: may increase cardiac toxicity risk. - Protease inhibitors (e.g., ritonavir): can raise mefloquine plasma levels.

Moderate Interactions (Monitor Closely): - Antacids: may reduce absorption; separate dosing by at least 2 hours. - CYP3A4 inducers (e.g., rifampicin): may lower effectiveness. - Oral contraceptives: potential reduction in contraceptive efficacy; advise additional protection.